Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock Position Lifted by Kovack Advisors Inc.

Kovack Advisors Inc. grew its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 8.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 133,792 shares of the company’s stock after acquiring an additional 9,917 shares during the quarter. Kovack Advisors Inc.’s holdings in Stereotaxis were worth $305,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in STXS. Traynor Capital Management Inc. bought a new position in Stereotaxis in the fourth quarter worth about $366,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Stereotaxis by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after purchasing an additional 15,491 shares during the last quarter. State Street Corp boosted its position in Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after purchasing an additional 36,518 shares during the period. Barclays PLC grew its stake in Stereotaxis by 449.9% during the 3rd quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in Stereotaxis by 7.2% in the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock worth $2,840,000 after buying an additional 93,253 shares during the period. 45.35% of the stock is owned by institutional investors and hedge funds.

Stereotaxis Trading Down 5.1 %

STXS stock opened at $2.06 on Friday. Stereotaxis, Inc. has a 1 year low of $1.66 and a 1 year high of $3.29. The firm has a market capitalization of $174.54 million, a price-to-earnings ratio of -7.36 and a beta of 1.54.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.